🌙
Average Insider
Where insiders trade, we follow
🔍
☰
🏠 Home
🔍 Search
🏢 Companies
📊 Cluster Buys
📄 Filings Search
💰 Earnings Calendar
📧 Newsletters
📝 Sign Up
🔐 Sign In
Buy/Sell Ratio
›
February 2026
›
Drug Manufacturers - Specialty & Generic Industry
Insider Buy/Sell Details for the Drug Manufacturers - Specialty & Generic Industry — February 2026
Extreme outlier transactions (>3σ) are excluded.
Show All Data
Ratio
0.1:1
Daily Buy & Sell Volume
Log Scale
Transactions
(4)
All (63)
Buys (4)
Sells (59)
Company
Insider
Title
Sort by
Date (newest)
Total Value
% of Holdings
Company Name
Apply
TALPHERA, INC.
(TLPH)
ASADORIAN RAFFI
— Chief Financial Officer
Feb 12, 2026
Purchase
Shares
45,000
Price
$0.81
Total Value
$36.55K
Shares Held After
91,256
% of Holdings
49.3%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
TALPHERA, INC.
(TLPH)
Aslam Shakil
— Chief Medical Officer
Feb 12, 2026
Purchase
Shares
35,000
Price
$0.81
Total Value
$28.43K
Shares Held After
83,178
% of Holdings
42.1%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
TALPHERA, INC.
(TLPH)
Angotti Vincent J.
— Director
Feb 12, 2026
Purchase
Shares
105,364
Price
$0.81
Total Value
$85.59K
Shares Held After
586,954
% of Holdings
18.0%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
TALPHERA, INC.
(TLPH)
Dasu Badri N
— Chief Engineering Officer
Feb 12, 2026
Purchase
Shares
35,000
Price
$0.81
Total Value
$28.43K
Shares Held After
76,230
% of Holdings
45.9%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Showing 1–4 of 4 transactions (page 1 of 1)
Version: v26.3.23